GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fusen Pharmaceutical Co Ltd (HKSE:01652) » Definitions » Price-to-Operating-Cash-Flow

Fusen Pharmaceutical Co (HKSE:01652) Price-to-Operating-Cash-Flow : (As of Jun. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Fusen Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-06-20), Fusen Pharmaceutical Co's share price is HK$1.17. Fusen Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.11. Hence, Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 9 years, Fusen Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 236.07. The lowest was 4.43. And the median was 14.17.

HKSE:01652's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.95
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Fusen Pharmaceutical Co's Cash Flow from Operations per share for the six months ended in Dec. 2023 was HK$-0.04. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.11.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Fusen Pharmaceutical Co was -165.60% per year.

During the past 9 years, Fusen Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 79.90% per year. The lowest was -51.30% per year. And the median was -0.60% per year.


Fusen Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusen Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Fusen Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only 171.43 19.61 16.32 8.77 -

Fusen Pharmaceutical Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.32 - 8.77 - -

Competitive Comparison of Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Fusen Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.17/-0.106
=

Fusen Pharmaceutical Co's Share Price of today is HK$1.17.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fusen Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Fusen Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fusen Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Fusen Pharmaceutical Co (HKSE:01652) Business Description

Traded in Other Exchanges
N/A
Address
Urban Industrial Zone, Henan Province, Xichuan County, Zhengzhou, CHN
Fusen Pharmaceutical Co Ltd is engaged in manufacturing shuanghuanglian based cold medicine. The product portfolio company includes shuanghuanglian based cold medicine and which includes oral solutions and shuanghuanglian injections, other PCM and western medicine products which include compound ferrous sulphate granules and flunarizine hydrochloride capsules.
Executives
Cao Changcheng 2201 Interest of corporation controlled by you
Quan Xiufeng 2202 Interest of your spouse
Full Bliss Holdings Limited 2101 Beneficial owner
One Victory Investments Limited 2101 Beneficial owner
Cao Zhiming 2201 Interest of corporation controlled by you
Zhou Peilin 2202 Interest of your spouse
Rayford Global Limited 2306 Nominee for another person
Tct (bvi) Limited 2501 Other
The Core Trust Company Limited 2301 Trustee
First Joint Elegant Limited 2101 Beneficial owner
Fung Wai Sze 2202 Interest of your spouse
Lam Yiu Por 2201 Interest of corporation controlled by you

Fusen Pharmaceutical Co (HKSE:01652) Headlines

No Headlines